...
首页> 外文期刊>Immunology, endocrine & metabolic agents in medicinal chemistry. >Eight-Year Follow-Up of an Initial Case with NF-kB Decoy Oligodeoxynu-cleotide Transfection After Coronary Stent Implantation
【24h】

Eight-Year Follow-Up of an Initial Case with NF-kB Decoy Oligodeoxynu-cleotide Transfection After Coronary Stent Implantation

机译:冠状动脉支架植入术后NF-kB诱骗性寡脱氧核糖核酸转染初始病例的八年随访。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Nuclear factor-kappa B (NF-kB) plays a pivotal role in vascular remodeling after percutaneous coronary intervention (PCI) with a stent implantation.Methods and Results: This is the first clinical report to demonstrate the effect of NF-kB decoy oligodeoxynucleotide (ODN) on the prevention of restenosis after an eight-year observation period. We revealed that decoy ODN treatment suppressed neointimal formation in comparison to that without ODN transfected stent lesion in the same artery.Conclusion: We showed the long-term usefulness of NF-kB decoy ODN transfer after PCI. ^g>CT, coronary intervention, gene therapy, nuclear factor-kappa B, oligodeoxynucleotide, restenosis, stents.
机译:背景:核因子-κB(NF-kB)在经支架植入的经皮冠状动脉介入治疗(PCI)后的血管重塑中起着关键作用。方法和结果:这是第一份证明NF-kB诱饵作用的临床报告八年观察期后,寡脱氧核苷酸(ODN)预防再狭窄。我们发现,与没有ODN转染支架的病变相比,诱饵ODN治疗可抑制新内膜形成。结论:我们证明了PCI后NF-kB诱饵ODN转移的长期有效性。 CT,冠状动脉介入治疗,基因治疗,核因子-κB,寡脱氧核苷酸,再狭窄,支架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号